ClinicalTrials.Veeva

Menu

Pulmonary Embolism Registry (PER)

U

Universidade do Porto

Status

Not yet enrolling

Conditions

Pulmonary Embolism

Study type

Observational

Funder types

Other

Identifiers

NCT05391646
PER2022

Details and patient eligibility

About

Acute Pulmonary Embolism (PE) is the most serious clinical presentation of venous thromboembolism (VTE), a leading cause of cardiovascular mortality, exceeded only by stroke and myocardial infarction. Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe chronic form of CTED and it occurs in 2-4% of patients after acute PE.

In Portugal little is known about PE epidemiology and its outcomes, including complications like CTED. The main goal of this study is, therefore, to understand PE epidemiology and complications in the northern region of Portugal. This information can enable the organization of a structured health care network that can potentially benefit all PE patients.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute symptomatic or asymptomatic PE,
  • Age >18 years,
  • Availability of a minimum data set for PE and a minimum of 3-months follow-up for the primary objective and 36-months for the secondary one. Except for patients who died prior to the 3 or 36 months follow-up.

Exclusion criteria

  • Enrolment of the patient in any treatment trial in a blinded fashion,
  • Lack or withdrawal of patient´s consent.

Trial contacts and locations

0

Loading...

Central trial contact

Carolina Guedes, MD, PhDc; Janete Santos, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems